Form 8-K - Current report:
SEC Accession No. 0001104659-21-069633
Filing Date
2021-05-20
Accepted
2021-05-20 09:07:16
Documents
16
Period of Report
2021-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117036d1_8k.htm   iXBRL 8-K 29391
2 EXHIBIT 10.1 tm2117036d1_ex10-1.htm EX-10.1 21343
3 EXHIBIT 99.1 tm2117036d1_ex99-1.htm EX-99.1 12293
7 GRAPHIC tm2117036d1_ex10-1img002.jpg GRAPHIC 563129
8 GRAPHIC tm2117036d1_ex99-1img001.jpg GRAPHIC 5296
  Complete submission text file 0001104659-21-069633.txt   1029036

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA immu-20210519.xsd EX-101.SCH 3187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20210519_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20210519_pre.xml EX-101.PRE 22711
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2117036d1_8k_htm.xml XML 3606
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 21942488
SIC: 2834 Pharmaceutical Preparations